Original ResearchImmune-inflammatory biomarkers as prognostic factors for immunotherapy in pretreated advanced urinary tract cancer patients: an analysis of the Italian SAUL cohort
Under a Creative Commons license
open access
Key words
biomarker
immunotherapy
PD-1
PD-L1
LDH
neutrophil-to-lymphocyte ratio (NLR)
systemic immune-inflammation index (SII)
immune-checkpoint inhibitor
prognostic
urothelial carcinoma
Cited by (0)
- †
These authors contributed equally.
- ‡
Previously with Azienda Ospedaliera Cannizzaro di Catania, Catania, Italy; [email protected].
- §
Previously with Azienda Ospedaliera S. Camillo Forlanini, Rome, Italy; [email protected].
© 2021 The Authors. Published by Elsevier Ltd on behalf of European Society for Medical Oncology.